- Does Puma's quick launch play into its buyout prospects? | Fierce Pharma
- Puma PHARMA
- (@pumabiotech) /
- Resumen: Puma Biotechnology y Fabre el acuerdo licencia de NERLYNX® para incluir la Gran China | Business
- Biotechnology
- Puma PHARMA
- Hering Pharma Muira Tincture Q 30ml ShopHealthy.in
- Puma Biotech Strikes Deal to Develop its Breast Cancer Drug in China - Los Business Journal
- Puma – PHARMA
- Resumen: Puma Biotechnology y Fabre el acuerdo licencia de NERLYNX® para incluir la Gran China | Business
- Puma Biotech In-Licenses Takeda's Cancer Candidate With Focus On & Lung Cancer
- Resumen: Biotechnology y Pierre Fabre firman acuerdo de licencia exclusiva para desarrollar y NERLYNX® (neratinib) en Europa | Business
- Puma Biotechnology 11-6 Scripps CME Connection
- Puma PHARMA
- Puma Too Little, Too Late, Much Of Bad Side Effect (NASDAQ:PBYI) | Seeking
- Biotechnology
- Medical Affairs eLearning -
- Puma Biotechnology, | LinkedIn
- Biotechnology Surging
- Ex-Puma exec charged with insider trading, hit with criminal | Fierce Biotech
- Puma Pharma (@PumaPharma) Twitter
- La EMA no aprobar el de Biotech
- BIOTECHNOLOGY, FORM 10-K - Biotech Due Diligence
- Puma Wins Extension of Patent Main Breast Treatment Drug Nerlynx - Los Angeles Journal
- Biotechnology